Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BAT1308 plus platinum chemotherapy ± bevacizumab vs placebo plus platinum chemotherapy ± bevacizumab in first-line PD-L1–positive recurrent or metastatic cervical cancer
CTR20262354Phase 3Active
- Sponsor
- Bio-Thera Solutions, Ltd.
- Start
- Feb 2025
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of BAT1308 in Cervical Cancer (CC), sponsored by Bio-Thera Solutions, Ltd.. Started Feb 2025; status: active.
02
Drugs
BAT1308
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on CTR20262354.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20262354.